Dr Tess Lawrie and Ivermectin Meta-Analysis

Data-analyst Dr. Tess Lawrie discusses how she came to perform her analyses of the successful use of ivermectin for the management of Covid-19 and the challenges to have her results accepted for implementation of potentially life-saving policies.

Media, NEW: Early Treatment, NEW: Featured, NEW: Integrative Therapy, NEW: Pandemic Management, NEW: Podcasts & Videos, NEW: Prevention & Treatment
Cochrane Review, COVID-19, evidence-based, ivermectin, meta-analysis, Video

Interview with Dr. Pelech regarding COVID-19 issues

Dr. Stephen Pelech provides an end of year review of the science that supports or refutes the public health policies imposed during the COVID-19 crisis.

Deanna McLeod Pt. 3: Big Pharma and Vaccine Conflict of Interest

Deanna McLeod’s interview on Open Mike with Mr. Michael Thiessen, on the topic of conflicts of interests surrounding the COVID-19 injections.

The Blind Spot in COVID-19 Vaccination Policies: Under Reported Adverse Events

In this peer-reviewed publication, Dr Patrick Provost examines the post-vaccination adverse events reporting system and the inherent weaknesses that may result in underreporting. Based on

Dr Tess Lawrie and Ivermectin Meta-Analysis

Dr Tess Lawrie and Ivermectin Meta-Analysis

Related Posts

Deanna McLeod Pt. 3: Big Pharma and Vaccine Conflict of Interest

Canadian Covid Care Alliance